HOME >> MEDICINE >> NEWS
Answers To Access, Adherence And Tolerance Of Protease Inhibitors

PROVIDENCE, R.I. - Protease inhibitors - the backbone ingredient of the potent triple therapy drug regimen - may not be performing as well in practice as they did in clinical trials, and some patients who could benefit from them may not be receiving them, according to three studies about access, adherence and tolerance of the potent drugs in 254 patients being treated at five urban sites in Boston and Rhode Island.

In one study, about 40 percent of 151 patients who tried one or more of the four available protease inhibitors eventually discontinued the drug. The most common reason patients gave was gastrointestinal and systemic side effects, followed by treatment failure, says lead author Valerie Stone, M.D., director of the Hope Center for HIV Care at Memorial Hospital in Pawtucket, R.I., and an assistant professor of medicine at Brown University.

"Patients can only benefit from protease inhibitors while they are taking the pills," Stone says. "If it turns out that regular patients in clinical practice aren't able to stick with the medications, they can't derive the benefits, such as increased survival and improved quality of life, that we've been led to expect." The take-home lesson is to optimize treatment regimens for individual patients and to closely manage side effects and toxicity, Stone says.

Despite the side effects and complex daily drug doses, most patients successfully adhere to their protease inhibitor therapy, except for those patients who have active substance abuse or alcohol problems, says another study Stone will present Wednesday, July 1.

Although they can stick to treatment, women, minorities and patients with less education are less likely to be offered potent drug cocktails containing protease inhibitors, according to another paper by Stone and colleagues to be given Thursday, July 2. "While combination regimens containing protease inhibitors can dramatically improve outcomes, not all patients who can benefit are receiving them
'"/>

Contact: Carol Cruzan Morton
carol_morton@brown.edu
401.863.2476
Brown University
30-Jun-1998


Page: 1 2

Related medicine news :

1. X-Rays: How Big A Risk To Kids? UF Researchers Seek Answers
2. Study Shows Child Health Plus Eases Access, But Some Barriers Remain
3. Tolerance for alcohol associated with family history
4. Teen Line Panel Of Six High School Students To Address The Issue Of Teens And Tolerance
5. Protease inhibitor could help prevent alzheimers
6. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
7. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
8. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
9. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors
10. Inhibitors prevent aggresome formation associated with some forms of ALS
11. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: